IDEAYA Biosciences (NASDAQ:IDYA) just reported results for the second quarter of 2024.
- IDEAYA Biosciences reported earnings per share of -68 cents. This was below the analyst estimate for EPS of -54 cents.
- The company did not report any revenue for the quarter.